Li Xinjie et al. (Li et al., 2011) and Shen TT et al. (Shen et al., 2015) found that the genetic phenotype of NAT2 in the Chinese Han population of patients with TB was predominantly intermediate, and the risk of drug-related liver injury was higher in the slow metabolic form of NAT2. Here, NAT2 is linked to tuberculosis.